Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3220756

Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors

Author
FINLAY, J. L; GOLDMAN, S; GEYER, J. R; HARRIS, R. E; SANDERS, J; YATES, A. J; BOYETT, J. M; PACKER, R. J; WONG M. C; CAIRO, M; GARVIN, J; AUGUST, C; COHEN, B. H; STANLEY, P; ZIMMERMAN, R. A; BOSTROM, B
Babies Hospital/Columbia University, New York, NY, United States
Children's Hospital Medical Center, Cincinnati OH, United States
Memorial Sloan-Kettering Cancer Center, New York NY, United States
Ohio State University, Columbus, OH, United States
Seattle Children's Hospital and The Fred Hutchinson Cancer Center, Seattle, WA, United States
St Jude Children's Research Hospital, Memphis, TN, United States
The Children's Cancer Group, Arcadia, CA, United States
The Children's Hospital of Los Angeles, Los Angeles, CA, United States
The Children's Hospital of Orange County, Orange, CA, United States
The Children's Hospital of Philadelphia, Philadelphia, PA, United States
The Children's National Medical Center, George Washington University, Washington, DC, United States
The Cleveland Clinic Foundation, Cleveland OH, United States
The University of Minnesota and Children's Health Care-Minneapolis, Minneapolis, MN, United States
University of Chicago, Chicago, IL, United States
Children's Cancer Group, United States
Source

Journal of clinical oncology. 1996, Vol 14, Num 9, pp 2495-2503 ; ref : 35 ref

ISSN
0732-183X
Scientific domain
Medical oncology
Publisher
Lippincott Williams & Wilkins, Baltimore, MD
Publication country
United States
Document type
Article
Language
English
Keyword (fr)
Adulte jeune Agent alkylant Anticancéreux Antimitotique Autogreffe Chimiothérapie DNA topoisomerase (ATP-hydrolysing) Dose forte Enfant Etoposide Greffe Inhibiteur enzyme Intracrânien Moelle osseuse Récidivant Thiotepa Traitement associé Tumeur maligne Podophyllotoxine dérivé Aziridine dérivé Encéphale pathologie Enzyme Homme Isomerases Système nerveux central pathologie Système nerveux pathologie Thiophosphoramidate organique Transfusion
Keyword (en)
Young adult Alkylating agent Antineoplastic agent Antimitotic Autograft Chemotherapy DNA topoisomerase (ATP-hydrolysing) High dose Child Graft Enzyme inhibitor Intracranial Bone marrow Recurrent Combined treatment Malignant tumor Podophyllotoxin derivatives Aziridine derivatives Cerebral disorder Enzyme Human Isomerases Central nervous system disease Nervous system diseases Organic thioamidophosphate Transfusion
Keyword (es)
Adulto joven Agente alquilante Anticanceroso Antimitótico Autoinjerto Quimioterapia DNA topoisomerase (ATP-hydrolysing) Dosis fuerte Niño Injerto Inhibidor enzima Intracraneal Médula ósea Recidivante Tratamiento asociado Tumor maligno Encéfalo patología Enzima Hombre Isomerases Sistema nervosio central patología Sistema nervioso patología Tiofosforamidato orgánico Transfusión
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R04 Combined treatments (chemotherapy of immunotherapy associated with an other treatment)

Discipline
Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
3220756

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web